US Stock MarketDetailed Quotes

RVNC Revance Therapeutics

Watchlist
  • 3.400
  • +0.110+3.34%
Close Apr 26 16:00 ET
  • 3.400
  • 0.0000.00%
Post 16:20 ET
354.33MMarket Cap-887P/E (TTM)

Revance Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-11.90%-216.58M
-41.58%-42.73M
11.94%-50.96M
-20.71%-53.38M
-13.43%-69.5M
12.63%-193.55M
32.34%-30.18M
-8.85%-57.87M
9.75%-44.23M
18.04%-61.27M
Net income from continuing operations
9.10%-323.99M
61.84%-55.7M
-66.69%-141.18M
-9.58%-67.32M
7.07%-59.79M
-26.70%-356.42M
-131.31%-145.95M
-13.87%-84.69M
14.91%-61.44M
10.19%-64.34M
Depreciation and amortization
-65.02%13.69M
-92.28%1.42M
-75.81%2.13M
-46.57%3.53M
23.10%6.62M
97.18%39.15M
239.14%18.38M
70.54%8.78M
31.05%6.61M
26.76%5.38M
Other non cash items
-2.15%3.04M
76.27%832K
-55.07%678K
11.62%701K
66.07%832K
165.81%3.11M
396.84%472K
285.93%1.51M
99.37%628K
35.77%501K
Change In working capital
-6,698.80%-43.88M
-82.53%3.18M
-1,217.26%-14.12M
-654.61%-4.45M
-65.19%-28.49M
113.93%665K
833.80%18.18M
-121.27%-1.07M
-87.69%802K
5.65%-17.25M
-Change in receivables
-104.48%-16.34M
-674.37%-2.26M
-36.29%-8.37M
-49.24%-1.67M
-259.22%-4.03M
-426.00%-7.99M
123.31%394K
-503.93%-6.14M
-124.62%-1.12M
66.55%-1.12M
-Change in inventory
-148.17%-14.91M
428.09%3.16M
-103.04%-6.42M
-36.36%-4.01M
-1,418.69%-7.64M
-40.44%-6.01M
1,473.68%598K
38.37%-3.16M
-621.81%-2.94M
-303.64%-503K
-Change in prepaid assets
-288.79%-6.79M
15.03%5.23M
-829.41%-8.91M
-816.75%-1.81M
-720.10%-1.3M
305.37%3.6M
165.92%4.54M
-111.35%-959K
34.98%-197K
106.95%209K
-Change in payables and accrued expense
-81.47%1.88M
-47.85%8.29M
115.00%9.42M
-55.36%2.38M
-17.51%-18.22M
102.28%10.12M
318.95%15.9M
-34.48%4.38M
4.69%5.34M
-46.54%-15.5M
-Change in other current assets
-386.75%-35.5M
-22.65%2.87M
-398.46%-16.33M
-98.51%786K
66.97%-22.83M
49.27%-7.29M
-59.08%3.71M
265.96%5.47M
355.51%52.64M
-15,188.86%-69.11M
-Change in other current liabilities
407.87%32.07M
-19.38%-5.58M
277.80%14.45M
98.64%-714K
-66.64%23.91M
-54.18%6.31M
-294.76%-4.67M
-2,055.44%-8.13M
-423.42%-52.55M
7,975.05%71.66M
-Change in other working capital
-322.18%-4.29M
-272.16%-8.53M
-72.67%2.04M
263.23%586K
156.03%1.62M
218.33%1.93M
-93.58%-2.29M
2,794.95%7.47M
-137.32%-359K
-154.77%-2.88M
Cash from discontinued investing activities
Operating cash flow
-11.90%-216.58M
-41.58%-42.73M
11.94%-50.96M
-20.71%-53.38M
-13.43%-69.5M
12.63%-193.55M
32.34%-30.18M
-8.85%-57.87M
9.75%-44.23M
18.04%-61.27M
Investing cash flow
Cash flow from continuing investing activities
179.06%109.74M
-94.21%2.37M
143.55%51.59M
62.66%-39.53M
113.87%95.32M
-367.88%-138.8M
48.19%40.96M
-804.74%-118.45M
-196.64%-105.88M
216.00%44.57M
Net PPE purchase and sale
-114.52%-6.89M
-38.12%-1.78M
-349.40%-4.5M
-50.37%266K
40.25%-870K
69.06%-3.21M
70.44%-1.29M
-140.11%-1M
111.96%536K
63.92%-1.46M
Net investment purchase and sale
204.94%121.51M
-87.23%5.65M
154.30%59.47M
60.39%-39.8M
92.43%96.19M
-899.03%-115.79M
38.22%44.23M
-597.63%-109.52M
-221.91%-100.48M
245.37%49.98M
Net other investing changes
75.34%-4.88M
24.24%-1.5M
----
----
----
-157.14%-19.8M
---1.98M
---7.92M
---5.94M
---3.96M
Cash from discontinued investing activities
Investing cash flow
179.06%109.74M
-94.21%2.37M
143.55%51.59M
62.66%-39.53M
113.87%95.32M
-367.88%-138.8M
48.19%40.96M
-804.74%-118.45M
-196.64%-105.88M
216.00%44.57M
Financing cash flow
Cash flow from continuing financing activities
-58.83%136.57M
73.61%-1.63M
-82.28%37.46M
360.53%97.47M
-96.90%3.27M
1,010.50%331.69M
-1,624.20%-6.17M
8,582.70%211.39M
626.82%21.17M
262.60%105.31M
Net issuance payments of debt
-65.35%30.16M
55.03%-2.74M
1,390.15%41.8M
-264.38%-6.41M
-102.53%-2.49M
--87.05M
---6.1M
---3.24M
---1.76M
--98.15M
Net common stock issuance
-59.61%100.18M
--0
--0
339.07%100.18M
--0
1,042.61%248.01M
--0
21,620,100.00%216.2M
2,281,600.00%22.82M
-58.55%9M
Proceeds from stock option exercised by employees
217.20%15.29M
-42.18%1.26M
-88.67%58K
119.19%4.49M
11,901.27%9.48M
-71.12%4.82M
31.46%2.18M
63.06%512K
-42.78%2.05M
-99.29%79K
Net other financing activities
-10.64%-9.07M
93.44%-148K
-111.19%-4.4M
59.38%-788K
-94.98%-3.73M
3.89%-8.19M
-79.98%-2.26M
25.74%-2.08M
-190.42%-1.94M
49.63%-1.91M
Cash from discontinued financing activities
Financing cash flow
-58.83%136.57M
73.61%-1.63M
-82.28%37.46M
360.53%97.47M
-96.90%3.27M
1,010.50%331.69M
-1,624.20%-6.17M
8,582.70%211.39M
626.82%21.17M
262.60%105.31M
Net cash flow
Beginning cash position
-0.56%115.02M
69.13%186.74M
97.31%148.66M
-29.46%144.1M
-0.56%115.02M
-65.68%115.67M
-16.50%110.41M
-55.96%75.34M
-19.22%204.28M
-65.68%115.67M
Current changes in cash
4,660.12%29.73M
-1,011.83%-41.99M
8.58%38.08M
103.53%4.56M
-67.18%29.08M
99.71%-652K
127.80%4.61M
190.27%35.07M
-57.66%-128.94M
205.33%88.61M
End cash Position
25.85%144.75M
25.85%144.75M
69.13%186.74M
97.31%148.66M
-29.46%144.1M
-0.56%115.02M
-0.56%115.02M
-16.50%110.41M
-55.96%75.34M
-19.22%204.28M
Free cash flow
-13.57%-223.46M
-41.44%-44.51M
5.79%-55.47M
-21.58%-53.12M
-12.19%-70.37M
15.16%-196.76M
35.73%-31.47M
-16.19%-58.87M
18.32%-43.69M
20.39%-62.73M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -11.90%-216.58M-41.58%-42.73M11.94%-50.96M-20.71%-53.38M-13.43%-69.5M12.63%-193.55M32.34%-30.18M-8.85%-57.87M9.75%-44.23M18.04%-61.27M
Net income from continuing operations 9.10%-323.99M61.84%-55.7M-66.69%-141.18M-9.58%-67.32M7.07%-59.79M-26.70%-356.42M-131.31%-145.95M-13.87%-84.69M14.91%-61.44M10.19%-64.34M
Depreciation and amortization -65.02%13.69M-92.28%1.42M-75.81%2.13M-46.57%3.53M23.10%6.62M97.18%39.15M239.14%18.38M70.54%8.78M31.05%6.61M26.76%5.38M
Other non cash items -2.15%3.04M76.27%832K-55.07%678K11.62%701K66.07%832K165.81%3.11M396.84%472K285.93%1.51M99.37%628K35.77%501K
Change In working capital -6,698.80%-43.88M-82.53%3.18M-1,217.26%-14.12M-654.61%-4.45M-65.19%-28.49M113.93%665K833.80%18.18M-121.27%-1.07M-87.69%802K5.65%-17.25M
-Change in receivables -104.48%-16.34M-674.37%-2.26M-36.29%-8.37M-49.24%-1.67M-259.22%-4.03M-426.00%-7.99M123.31%394K-503.93%-6.14M-124.62%-1.12M66.55%-1.12M
-Change in inventory -148.17%-14.91M428.09%3.16M-103.04%-6.42M-36.36%-4.01M-1,418.69%-7.64M-40.44%-6.01M1,473.68%598K38.37%-3.16M-621.81%-2.94M-303.64%-503K
-Change in prepaid assets -288.79%-6.79M15.03%5.23M-829.41%-8.91M-816.75%-1.81M-720.10%-1.3M305.37%3.6M165.92%4.54M-111.35%-959K34.98%-197K106.95%209K
-Change in payables and accrued expense -81.47%1.88M-47.85%8.29M115.00%9.42M-55.36%2.38M-17.51%-18.22M102.28%10.12M318.95%15.9M-34.48%4.38M4.69%5.34M-46.54%-15.5M
-Change in other current assets -386.75%-35.5M-22.65%2.87M-398.46%-16.33M-98.51%786K66.97%-22.83M49.27%-7.29M-59.08%3.71M265.96%5.47M355.51%52.64M-15,188.86%-69.11M
-Change in other current liabilities 407.87%32.07M-19.38%-5.58M277.80%14.45M98.64%-714K-66.64%23.91M-54.18%6.31M-294.76%-4.67M-2,055.44%-8.13M-423.42%-52.55M7,975.05%71.66M
-Change in other working capital -322.18%-4.29M-272.16%-8.53M-72.67%2.04M263.23%586K156.03%1.62M218.33%1.93M-93.58%-2.29M2,794.95%7.47M-137.32%-359K-154.77%-2.88M
Cash from discontinued investing activities
Operating cash flow -11.90%-216.58M-41.58%-42.73M11.94%-50.96M-20.71%-53.38M-13.43%-69.5M12.63%-193.55M32.34%-30.18M-8.85%-57.87M9.75%-44.23M18.04%-61.27M
Investing cash flow
Cash flow from continuing investing activities 179.06%109.74M-94.21%2.37M143.55%51.59M62.66%-39.53M113.87%95.32M-367.88%-138.8M48.19%40.96M-804.74%-118.45M-196.64%-105.88M216.00%44.57M
Net PPE purchase and sale -114.52%-6.89M-38.12%-1.78M-349.40%-4.5M-50.37%266K40.25%-870K69.06%-3.21M70.44%-1.29M-140.11%-1M111.96%536K63.92%-1.46M
Net investment purchase and sale 204.94%121.51M-87.23%5.65M154.30%59.47M60.39%-39.8M92.43%96.19M-899.03%-115.79M38.22%44.23M-597.63%-109.52M-221.91%-100.48M245.37%49.98M
Net other investing changes 75.34%-4.88M24.24%-1.5M-------------157.14%-19.8M---1.98M---7.92M---5.94M---3.96M
Cash from discontinued investing activities
Investing cash flow 179.06%109.74M-94.21%2.37M143.55%51.59M62.66%-39.53M113.87%95.32M-367.88%-138.8M48.19%40.96M-804.74%-118.45M-196.64%-105.88M216.00%44.57M
Financing cash flow
Cash flow from continuing financing activities -58.83%136.57M73.61%-1.63M-82.28%37.46M360.53%97.47M-96.90%3.27M1,010.50%331.69M-1,624.20%-6.17M8,582.70%211.39M626.82%21.17M262.60%105.31M
Net issuance payments of debt -65.35%30.16M55.03%-2.74M1,390.15%41.8M-264.38%-6.41M-102.53%-2.49M--87.05M---6.1M---3.24M---1.76M--98.15M
Net common stock issuance -59.61%100.18M--0--0339.07%100.18M--01,042.61%248.01M--021,620,100.00%216.2M2,281,600.00%22.82M-58.55%9M
Proceeds from stock option exercised by employees 217.20%15.29M-42.18%1.26M-88.67%58K119.19%4.49M11,901.27%9.48M-71.12%4.82M31.46%2.18M63.06%512K-42.78%2.05M-99.29%79K
Net other financing activities -10.64%-9.07M93.44%-148K-111.19%-4.4M59.38%-788K-94.98%-3.73M3.89%-8.19M-79.98%-2.26M25.74%-2.08M-190.42%-1.94M49.63%-1.91M
Cash from discontinued financing activities
Financing cash flow -58.83%136.57M73.61%-1.63M-82.28%37.46M360.53%97.47M-96.90%3.27M1,010.50%331.69M-1,624.20%-6.17M8,582.70%211.39M626.82%21.17M262.60%105.31M
Net cash flow
Beginning cash position -0.56%115.02M69.13%186.74M97.31%148.66M-29.46%144.1M-0.56%115.02M-65.68%115.67M-16.50%110.41M-55.96%75.34M-19.22%204.28M-65.68%115.67M
Current changes in cash 4,660.12%29.73M-1,011.83%-41.99M8.58%38.08M103.53%4.56M-67.18%29.08M99.71%-652K127.80%4.61M190.27%35.07M-57.66%-128.94M205.33%88.61M
End cash Position 25.85%144.75M25.85%144.75M69.13%186.74M97.31%148.66M-29.46%144.1M-0.56%115.02M-0.56%115.02M-16.50%110.41M-55.96%75.34M-19.22%204.28M
Free cash flow -13.57%-223.46M-41.44%-44.51M5.79%-55.47M-21.58%-53.12M-12.19%-70.37M15.16%-196.76M35.73%-31.47M-16.19%-58.87M18.32%-43.69M20.39%-62.73M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg